Pfizer PBC 125 (Ibrance 125 mg)
Generic Name: palbociclib
Pill with imprint Pfizer PBC 125 is Purple, Elliptical / Oval and has been identified as Ibrance 125 mg. It is supplied by Pfizer Inc..
Ibrance is used in the treatment of breast cancer, metastatic; breast cancer, male; liposarcoma; breast cancer and belongs to the drug class CDK 4/6 inhibitors. Ibrance 125 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Pfizer PBC 125
Ibrance
- Generic Name
- palbociclib
- Imprint
- Pfizer PBC 125
- Strength
- 125 mg
- Color
- Purple
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Cdk 4/6 inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pfizer Inc.
- National Drug Code (NDC)
- 00069-0688
Related Images for "Pfizer PBC 125"
More about Ibrance (palbociclib)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 61 Reviews
- Drug class: CDK 4/6 inhibitors
- FDA Alerts (1)
- FDA Approval History
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.